Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)
Bangladesh · Delayed Price · Currency is BDT 58.80
+0.20 (0.34%)
At close: May 6, 2026
Navana Pharmaceuticals Market Cap
Navana Pharmaceuticals has a market cap or net worth of 6.32 billion as of May 6, 2026. Its market cap has increased by 20.00% in one year.
Market Cap
6.32B
Enterprise Value
10.21B
Revenue
10.07B
Ranking
n/a
PE Ratio
10.41
Stock Price
58.80
Market Cap Chart
Since October 18, 2022, Navana Pharmaceuticals's market cap has increased from 2.84B to 6.32B, an increase of 122.73%. That is a compound annual growth rate of 25.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 6.32B | 13.29% |
| Dec 30, 2025 | 5.57B | 6.79% |
| Dec 30, 2024 | 5.22B | -42.42% |
| Dec 28, 2023 | 9.07B | 7.79% |
| Dec 29, 2022 | 8.41B | 196.59% |
| Oct 18, 2022 | 2.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beacon Pharmaceuticals | 23.42B |
| The ACME Laboratories | 15.87B |
| Asiatic Laboratories | 13.15B |
| The IBN SINA Pharmaceutical Industry | 9.61B |
| Orion Pharma | 5.97B |
| Techno Drugs | 4.87B |
| Ambee Pharmaceuticals | 1.81B |
| Pharma Aids | 1.75B |